Evaluation of biomarkers of exposure in smokers switching to a carbon-heated tobacco product: A controlled, randomized, open-label 5-day exposure study

Nicotine and Tobacco Research

Volumn 18, Issue 7, 2016, Pages 1606-1613

  Lüdicke, Frank ^a   Haziza, Christelle ^a   Weitkunat, Rolf ^a   Magnette, John ^a  

^a Philip Morris Products SA ^*  (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

4 (METHYLNITROSAMINO) 1 (3 PYRIDYL) 1 BUTANOL; ACETYLCYSTEINE; BIOLOGICAL MARKER; CARBOXYHEMOGLOBIN; CIGARETTE SMOKE; NICOTINE; PHENYLMERCAPTURIC ACID; TOBACCO SMOKE; UNCLASSIFIED DRUG;

ADULT; ARTICLE; BLOOD SAMPLING; CONTROLLED STUDY; FEMALE; HEADACHE; HUMAN; MALE; MUTAGENICITY; OPEN STUDY; PRIORITY JOURNAL; RISK ASSESSMENT; SMOKING; SMOKING CESSATION; TOBACCO USE; URINARY EXCRETION; BLOOD; ELECTRONIC CIGARETTE; HARM REDUCTION; METABOLISM; MIDDLE AGED; POLAND; PREVENTION AND CONTROL; PROCEDURES; PSYCHOLOGY; RANDOMIZED CONTROLLED TRIAL; TREATMENT OUTCOME; URINE; YOUNG ADULT;

ADULT; BIOMARKERS; CARBOXYHEMOGLOBIN; ELECTRONIC CIGARETTES; FEMALE; HARM REDUCTION; HUMANS; MALE; MIDDLE AGED; NICOTINE; POLAND; SMOKING; SMOKING CESSATION; TREATMENT OUTCOME; YOUNG ADULT;

EID: 84977083352     PISSN: 14622203     EISSN: 1469994X     Source Type: Journal    
DOI: 10.1093/ntr/ntw022     Document Type: Article

References (34)

1. IOM (Institute of Medicine). Clearing the Smoke -Assessing the Science Base for Tobacco Harm Reduction. Washington, DC: The National Academies Press; 2001. www.nap.edu/read/10029/chapter/1. Accessed November 26, 2015.
2. Slade J. Nicotine delivery device. In: Orleans CT, Slade J, eds. Nicotine Addiction: Principles and Management. New York, NY: Oxford University Press; 1993:3-23.
3. Pederson LL, Nelson DE. Literature review and summary of perceptions, attitudes, beliefs, and marketing of potentially reduced exposure products: communication implications. Nicotine Tob Res. 2007;9(5):525-534. doi:10.1080/14622200701239548.
4. Felter JL, Lee RL, Solanky A, et al.; Philip Morris USA. Electrically heated cigarette smoking system with internal manifolding for puff detection. US6810883 B2. November 8, 2002.
5. Buchhalter AR, Eissenberg T. Preliminary evaluation of a novel smoking system: effects on subjective and physiological measures and on smoking behavior. Nicotine Tob Res. 2000;2(1):39-43. doi:10.1080/14622200050011286.
6. Holzman D. Safe cigarette alternatives? Industry critics say 'not yet'. J Natl Cancer Inst. 1999;91(6):502-504. doi:10.1093/jnci/91.6.502.
7. Caraballo RS, Pederson LL, Gupta N. New tobacco products: do smokers like them? Tob Control. 2006;15(1):39-44. doi:10.1136/tc.2005.012856.
8. FDA (Food and Drug Administration). Guidance for Industry -Modified Risk Tobacco Product Applications -Draft Guidance. 2012. www.fda.gov/downloads/TobaccoProducts/GuidanceComplianceRegulatoryInformation/UCM297751.pdf. Accessed November 26, 2015.
9. Kogel U, Schlage WK, Martin F, et al. A 28-day rat inhalation study with an integrated molecular toxicology endpoint demonstrates reduced exposure effects for a prototypic modified risk tobacco product compared with conventional cigarettes. Food Chem Toxicol. 2014;68:204-217. doi:10.1016/j.fct.2014.02.034.
10. Talikka M, Sierro N, Ivanov NV, et al. Genomic impact of cigarette smoke, with application to three smoking-related diseases. Crit Rev Toxicol. 2012;42(10):877-889. doi:10.3109/10408444.2012.725244.
11. Phillips B, Veljkovic E, Peck MJ, et al. A 7-month cigarette smoke inhalation study in C57BL/6 mice demonstrates reduced lung inflammation and emphysema following smoking cessation or aerosol exposure from a prototypic modified risk tobacco product. Food Chem Toxicol. 2015;80:328, doi:10.1016/j.fct.2015.03.009.
12. van der Toorn M, Frentzel S, Goedertier D, Peitsch M, Hoeng J, De Leon H. A prototypic modified risk tobacco product exhibits reduced effects on chemotaxis and transendothelial migration of monocytes compared with a reference cigarette. Food Chem Toxicol. 2015;80:277-286. doi:10.1016/j.fct.2015.03.026.
13. Benowitz NL, Jacob P III, Bernert JT, et al. Carcinogen exposure during short-term switching from regular to "light" cigarettes. Cancer Epidemiol Biomarkers Prev. 2005;14(6):1376-1383. doi:10.1158/1055-9965.EPI-04-0667.
14. Heatherton TF, Kozlowski LT, Frecker RC, Fagerström KO. The Fagerström test for Nicotine Dependence: a revision of the Fagerström Tolerance Questionnaire. Br J Addict. 1991;86(9):1119-1127. www.dartmouth.edu/~thlab/pubs/91_Heatherton_etal_BJA.pdf. Accessed November 26, 2015.
15. Einisto P, Nohmi T, Watanabe M, Ishidate M Jr. Sensitivity of Salmonella typhimurium YG1024 to urine mutagenicity caused by cigarette smoking. Mutat Res. 1990;245(2):87-92. www.sciencedirect.com/science/article/pii/0165799290900055. Accessed November 26, 2015.
16. Scherer G, Urban M, Engl J, Hagedorn HW, Riedel K. Influence of smoking charcoal filter tipped cigarettes on various biomarkers of exposure. Inhal Toxicol. 2006;18(10):821-829. doi:10.1080/08958370600747945.
17. Sarkar M, Kapur S, Frost-Pineda K, et al. Evaluation of biomarkers of exposure to selected cigarette smoke constituents in adult smokers switched to carbon-filtered cigarettes in short-term and long-term clinical studies. Nicotine Tob Res. 2008;10(12):1761-1772. doi:10.1080/14622200802443718.
18. Carmella SG, Chen M, Han S, et al. Effects of smoking cessation on eight urinary tobacco carcinogen and toxicant biomarkers. Chem Res Toxicol. 2009;22(4):734-741. Erratum in Chem Res Toxicol. 2012 Mar 19;25(3):763. doi:10.1021/tx800479s.
19. IARC (International Agency for Research on Cancer). Monographs on the Evaluation of Carcinogenic Risks to Humans: Chemical Agents and Related Occupations. Vol 100F. Geneva, Switzerland: WHO Press; 2012. http://apps.who.int/bookorders/anglais/detart1.jsp?sesslan=1&codlan=1&codcol=72&codcch=6100. Accessed November 26, 2015.
20. Boogaard PJ, van Sittert NJ. Suitability of S-phenyl mercapturic acid and trans-trans-muconic acid as biomarkers for exposure to low concentrations of benzene. Environ Health Perspect. 1996;104(suppl 6):1151-1157. www.ncbi.nlm.nih.gov/pmc/articles/PMC1469762. Accessed November 26, 2015.
21. Riedel K, Scherer G, Engl J, Hagedorn HW, Tricker AR. Determination of three carcinogenic aromatic amines in urine of smokers and nonsmokers. J Anal Toxicol. 2006;30(3):187-195. doi:10.1093/jat/30.3.187.
22. Jongeneelen FJ, Anzion RB, Scheepers PT, et al. 1-Hydroxypyrene in urine as a biological indicator of exposure to polycyclic aromatic hydrocarbons in several work environments. Ann Occup Hyg. 1988;32(1):35-43. doi:10.1093/annhyg/32.1.35.
23. U.S. Department of Health and Human Services, Public Health Service, Agency for Toxic Substances and Disease Registry. Toxicological Profile for Carbon Monoxide. 2012. www.atsdr.cdc.gov/toxprofiles/tp201.pdf. Accessed November 23, 2014.
24. Hecht SS, Carmella SG, Chen M, et al. Quantitation of urinary metabolites of a tobacco-specific lung carcinogen after smoking cessation. Cancer Res. 1999;59(3):590-596. http://cancerres.aacrjournals.org/content/59/3/590. long. Accessed November 26, 2015.
25. Hecht SS. Metabolic activation and detoxification of tobacco-specific nitrosamines-a model for cancer prevention strategies. Drug Metab Rev. 1994;26(1-2):373-390. doi:10.3109/03602539409029803.
26. Mure K, Hayatsu H, Takeuchi T, Takeshita T, Morimoto K. Heavy cigarette smokers show higher mutagenicity in urine. Mutat Res. 1997;373(1):107-doi:10.1016/S0027-5107(96)00195-9.
27. Theophilus EH, Coggins CRE, Chen P, Schmidt ER, Borgerding MF. Magnitudes of biomarker reductions in response to controlled reductions in cigarettes smoked per day: a one-week clinical confinement study. Regul Toxicol Pharmacol. 2015;71(2):225-234. doi:10.1016/j.yrtph.2014.12.023.
28. Tricker AR, Jang IJ, Martin Leroy C, Lindner D, Dempsey R. Reduced exposure evaluation of an Electrically Heated Cigarette Smoking System. Part 4: eight-day randomized clinical trial in Korea. Regul Toxicol Pharmacol. 2012;64(suppl 2):S45-53. doi:10.1016/j.yrtph.2012.08.
29. Marian C, O'Connor RJ, Djordjevic MV, Rees VW, Hatsukami DK, Shields PG. Reconciling human smoking behavior and machine smoking patterns: implications for understanding smoking behavior and the impact on laboratory studies. Cancer Epidemiol Biomarkers Prev. 2009;18(12):3305-3320 doi:10.1158/1055-9965.EPI-09-1014.
30. Rees VW, Wayne GF, Connolly GN. Puffing style and human exposure minimally altered by switching to a carbon-filtered cigarette. Cancer Epidemiol Biomarkers Prev. 2008;17(11):2995-3003. doi:10.1158/1055-9965.EPI-07-2533.
31. Benowitz NL, Hall SM, Stewart S, Wilson M, Dempsey D, Jacob P III. Nicotine and carcinogen exposure with smoking of progressively reduced nicotine content cigarette. Cancer Epidemiol Biomarkers Prev. 2007;16(11):2479-2485. doi:10.1158/1055-9965.EPI-07-0393.
32. Hatsukami DK, Kotlyar M, Hertsgaard LA, et al. Reduced nicotine content cigarettes: effects on toxicant exposure, dependence and cessation. Addiction. 2010;105(2):343-355. doi:10.1158/1055-9965. EPI-07-0393.
33. Fiore M, Baker T. Reduced nicotine cigarettes -A promising regulatory pathway. N Engl J Med. 2015;373(14):1289-1291. doi:10.1056/ NEJMp1509510.
34. Hu Q, Hou H. Tobacco Smoke Exposure Biomarkers. Boca Raton, FL: CRC Press, Taylor & Francis Group; 2015.